lymph leakage
Conditions
Interventions
experimental group :Before abdominal closure, spray 5 mL of Pseudomonas aeruginosa injection mixed with 15 mL of normal saline onto the lymph node dissection bed.
control group:Before abdominal closure, spray 20 mL of normal saline onto the lymph node dissection bed.
Sponsors
The First Affiliated Hospital of Xiamen University
Eligibility
Sex/Gender
Female
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Patients diagnosed with gynaecological malignant tumours and undergoing surgical treatment, who need to undergo pelvic abdominal lymph node resection to the renal vein level during the operation; 2. No history of radiotherapy and chemotherapy before surgery, and no serious internal surgery complications; 3. All patients are operated by the same surgeon; 4. The clinical data is complete.
Exclusion criteria
Exclusion criteria: 1. Those who have not undergone standard surgical treatment due to acute abdomen and other reasons; 2. Patients with primary malignant tumours of other organs; 3. Those who are unable to cooperate and complete the experiment with severe mental illness, cognitive impairment, etc.; 4. Patients with a history of severe cardiopulmonary disease, liver and kidney disfunction, infectious diseases or pelvic radiotherapy; 5. People who are allergic to Pseudomonas aeruginosa injection.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postoperative daily drainage volume;duration of catheter indwelling;ncidence of lymphatic leakage; | — |
Secondary
| Measure | Time frame |
|---|---|
| postoperative hospital stay;incidence of lymphocele;incidence of lower limb edema; | — |
Countries
China
Contacts
Public ContactJianfa Lan
The First Affiliated Hospital of Xiamen University
Outcome results
None listed